Saudi Pharmaceutical Journal (Aug 2021)

Concurrent validity of the Arabic version of General Medication Adherence Scale using two validated indirect adherences measures in Saudi patients with non-communicable diseases

  • Md. Ashraful Islam,
  • Zeb-Un- Nisa,
  • Abdullah Isa Almuzel,
  • Hani Sadiq Al Afif,
  • Laila Hussain Al Rabia,
  • Muhammad Shahid Iqbal,
  • Azfar Athar Ishaqui,
  • Muhammad Zahid Iqbal,
  • Mohammad Akbar Hossain,
  • Abdul Haseeb,
  • Shazia Jamshed,
  • Atta Abbas Naqvi,
  • Sunil Kripalani

Journal volume & issue
Vol. 29, no. 8
pp. 874 – 878

Abstract

Read online

Purpose: This study aimed to evaluate the concurrent validity of the Arabic version of the General Medication Adherence Scale (GMAS) using two validated scales namely Adherence to Refills and Medications Scale (ARMS) and Medication Adherence Rating Scale (MARS) in Saudi patients with non-communicable diseases. Methods: A cross sectional study was conducted for 2 months in out-patient departments at a tertiary care hospital in Khobar, Saudi Arabia. The study collected data from patients with chronic illnesses through convenience sampling. Pearson correlation (ρ) was conducted to report concurrent validity of GMAS. A correlation coefficient value ≥ 0.5 with p-value SAR 10,000, i.e., USD 2666.2 (56.4%). The mean adherence scores obtained from MARS, ARMS and GMAS were 7.09, 19.9, and 27.4. The correlation (ρ) between GMAS and MARS scores was 0.65, and between GMAS and ARMS scores was −0.79, p < 0.01 for both comparisons. Conclusion: The concurrent validity of GMAS-AR was established in this study that would further substantiate psychometric properties of the scale in this population.

Keywords